Related Tags >> FDA milestones King Pharmaceuticals Merck KgAA

ZymoGenetics News

Most Popular ZymoGenetics Story

ZymoGenetics shares plunge after risks halt trial

October 28, 2008 — 9:09am ET | By John Carroll

Shares of ZymoGenetics were battered yesterday after the company announced that Merck KGaA had discontinued a trial on a partnered therapeutic after researchers noted a high risk of infection for... Read more...

ZymoGenetics Press Releases

PRESS RELEASE: ZymoGenetics Presents Positive Interim Phase 1 Results for IL-21

Latest Headlines

ZymoGenetics shares plunge after risks halt trial
October 28, 2008
ZymoGenetics lines up $100M
June 30, 2008
ALSO NOTED: New York pumps biotech complex; Investors focus on NZ biotech; Questions about anti-TNF safety;and much more...
June 5, 2008
ALSO NOTED: ZymoGenetics to chop jobs; Evotec extends collaboration; Iomai touts results for vaccine patch; and much more...
February 14, 2008
FDA approves ZymoGenetics' rThrombin
January 18, 2008
ALSO NOTED: Solvay drug 'approvable'; ChemGenex touts trial results: Asuragen raises $18.5M in venture cash; and much more...
December 10, 2007
SPOTLIGHT: King asks FDA to block ZymoGenetics' drug
November 2, 2007
ALSO NOTED: Pharma growth sinking to historic low; Neurocrine gains Japanese partner; OccuLogix suspends development program;an
November 1, 2007
ZymoGenetics deal for rThrombin hits a hurdle
August 23, 2007
Press Release: ZymoGenetics and Serono to Begin TACI-Ig Clinical Studies in B-Cell Malignancies
November 9, 2006

Paid Research Reports